Cargando…

Prognostic Performance of Peripheral Blood Biomarkers in Identifying Seropositive Individuals at Risk of Developing Clinically Symptomatic Chagas Cardiomyopathy

Biomarkers for prognosis-based detection of Trypanosoma cruzi-infected patients presenting no clinical symptoms to cardiac Chagas disease (CD) are not available. In this study, we examined the performance of seven biomarkers in prognosis and risk of symptomatic CD development. T. cruzi-infected pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choudhuri, Subhadip, Bhavnani, Suresh K., Zhang, Weibin, Botelli, Valentina, Barrientos, Natalia, Iñiguez, Facundo, Zago, Maria Paola, Garg, Nisha Jain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552597/ https://www.ncbi.nlm.nih.gov/pubmed/34479416 http://dx.doi.org/10.1128/spectrum.00364-21

Ejemplares similares

Potential Utility of Protein Targets of Cysteine-S-Nitrosylation in Identifying Clinical Disease Status in Human Chagas Disease
por: Zago, Maria Paola, et al.
Publicado: (2019)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection
por: Lokugamage, Nandadeva, et al.
Publicado: (2020)

Origin of Monocytes/Macrophages Contributing to Chronic Inflammation in Chagas Disease: SIRT1 Inhibition of FAK-NFκB-Dependent Proliferation and Proinflammatory Activation of Macrophages
por: Wan, Xianxiu, et al.
Publicado: (2019)

Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease
por: Garg, Nisha Jain, et al.
Publicado: (2016)

Mitochondrial Regulation of Macrophage Response Against Pathogens
por: Choudhuri, Subhadip, et al.
Publicado: (2021)

Genome Wide Association Study (GWAS) of Chagas Cardiomyopathy in Trypanosoma cruzi Seropositive Subjects
por: Deng, Xutao, et al.
Publicado: (2013)

Oxidative Stress in Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2009)

Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy
por: Malcolm, Elizabeth L., et al.
Publicado: (2022)

Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis
por: Dhiman, Monisha, et al.
Publicado: (2012)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

Chagas Cardiomyopathy Presenting as Symptomatic Bradycardia: An Underappreciated Emerging Public Health Problem in the United States
por: Durrance, Richard Jesse, et al.
Publicado: (2017)

Innate Immune Responses and Antioxidant/Oxidant Imbalance Are Major Determinants of Human Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

Clinical Presentations of Chagas Cardiomyopathy
por: Shehadeh, Malik, et al.
Publicado: (2020)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2013)

Manganese superoxide dismutase deficiency exacerbates the mitochondrial ROS production and oxidative damage in Chagas disease
por: Wen, Jake J., et al.
Publicado: (2018)

Immunologic changes are detectable in the peripheral blood transcriptome of clinically asymptomatic Chagas cardiomyopathy patients
por: Duque, Carolina, et al.
Publicado: (2023)

Integrated Functional Analysis of the Nuclear Proteome of Classically and Alternatively Activated Macrophages
por: Wiktorowicz, John E., et al.
Publicado: (2019)

Chagas Disease Cardiomyopathy: Immunopathology and Genetics
por: Cunha-Neto, Edecio, et al.
Publicado: (2014)

Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women
por: Mack, Ines, et al.
Publicado: (2017)

Genetic association study of NLRP1, CARD, and CASP1 inflammasome genes with chronic Chagas cardiomyopathy among Trypanosoma cruzi seropositive patients in Bolivia
por: Clipman, Steven J., et al.
Publicado: (2018)

Chagas Cardiomyopathy in the Context of the Chronic Disease Transition
por: Hidron, Alicia I., et al.
Publicado: (2010)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

Prevalence of Chagas heart disease in dilated cardiomyopathy
por: González-Zambrano, Héctor, et al.
Publicado: (2021)

PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance
por: Wen, Jake Jianjun, et al.
Publicado: (2018)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
por: de Souza Pimentel, Walace, et al.
Publicado: (2012)

Pathogenesis of Chagas Cardiomyopathy: Role of Inflammation and Oxidative Stress
por: Machado, Fabiana S., et al.
Publicado: (2013)

Imaging Diagnosis of Right Ventricle Involvement in Chagas Cardiomyopathy
por: Romano, Minna M. D., et al.
Publicado: (2017)

Advanced management of ventricular arrhythmias in chronic Chagas cardiomyopathy
por: Santacruz, David, et al.
Publicado: (2021)

MnSOD(tg) Mice Control Myocardial Inflammatory and Oxidative Stress and Remodeling Responses Elicited in Chronic Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain: Win, Miranda prediction of Chagas cardiomyopathy
por: Win, Sithu, et al.
Publicado: (2022)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Association of SARS-CoV-2 Seropositivity and Symptomatic Reinfection in Children in Nicaragua
por: Kubale, John, et al.
Publicado: (2022)

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy
por: González-Alcaide, Gregorio, et al.
Publicado: (2018)

Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy
por: Echeverría, Luis E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mbpju6cdl00d5ad1srnbom8vmj